OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-04-30-accounts

REGISTERED CHARITY NUMBER: 505256

Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 30 April 2022

for

Kidneys For Life

Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB

Kidneys For Life

Contents of the Financial Statements for the Year Ended 30 April 2022

Page
Report of the Trustees 1 to 4
Independent Examiner's Report 5
Statement of Financial Activities 6
Balance Sheet 7 to 8
Notes to the Financial Statements 9 to 18
Detailed Statement of Financial Activities 19 to 20

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2022

The trustees present their report with the financial statements of the charity for the year ended 30 April 2022. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Our mission

The strategic aim of Kidneys for Life fundraising for MINT (Manchester Institute for Nephrology & Transplantation) is the relief of renal related illnesses and the funding of research and education in renal disease, transplantation and allied fields together with the provision of direct patient amenities.

Objectives

Kidneys for Life's objectives and main activities are to undertake charitable fundraising and the provision of those funds for the research and education in renal disease and allied fields and the provision of direct patient amenities.

The trustees confirm that they have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the Trust's aims and objectives and in planning future activities and setting the grant making policy for the year.

Significant activities

The main activities currently carried out for the public benefit by the charity can be broadly categorised into the following:-

The beneficiaries of our main activities are ultimately sufferers of renal related diseases and those at risk of developing this disease in the future together with their families/carers. There are increasing numbers of people in the UK with some form of kidney disease and this is on the rise due to increased life expectancy and less healthier lifestyles. Developments in the care and treatment of those suffering from kidney disease has also the potential to relieve the huge burden of care often faced by the families and/or carers of sufferers. Our research and educational programmes funds researchers and renal staff who use these funds in their work to improve the lives of sufferers from kidney disease and related conditions, and their carers by developing therapies, potential medications and improvements in the personal care of sufferers. Any benefit received by researchers is purely incidental to the objects of our work.

MINT is a member of the Association of Medical Research Charities and follows best practice in maintaining the independence of research funding and ensuring that sponsored researchers abide by best practice in research ethics and animal testing; our aim is to maximise the efficiency of the research programme whilst minimising the likelihood of harm to research volunteers and animals.

How we work

The charity delivers its main aims in a number of ways including:-

Academic ability and research potential are the primary determinants of our bursaries and grants and other factors such as nationality, ethnicity, gender, age, disability, sexual orientation and religion will not be taken into account.

Page 1

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2022

OBJECTIVES AND ACTIVITIES

In addition to this the charity also funds direct patient amenities for those suffering from renal disease or related diseases and this provision is not dependent upon factors such as nationality, ethnicity, gender, age, disability, sexual orientation and religion.

ACHIEVEMENT AND PERFORMANCE Review of our achievements this financial year

The benefits of the charities work is the research into renal related diseases, education of renal staff, the dissemination of research findings, the development of new therapies and the funding of on-going research with the goal being to assist sufferers of renal related diseases, their carers and families. The trustees are pleased that the achievements and performance of the Charity as set out below with more detail on expenditure items, demonstrate our commitment to relieving the suffering of those with renal related diseases:-

More information of our research projects and researchers can be found on our website.

FINANCIAL REVIEW Results

The total incoming resources for the year amount to £203,991 (2021 - £112,956). The charity expenditure for the financial year was £168,536 (2021 - £134,584).

The current market value of the KFL investment portfolio at the year end was £290,601.

Whilst the impact of Covid-19 still affected many of the scheduled Kidneys for Life fundraising activities, this financial year saw a significant improvement on the previous 12 month period. In particular, running & skydiving events generated far greater income than in previous years. We were also beneficiaries of a generous In Memory donation made by the family of a patient. We continued with a cautious approach to spend and indeed our spend on Travel Grants and Nurse Education grants was low - this is due to overseas conferences and training courses either not taking place or taking the hybrid format hence little travel expenditure was incurred.

Page 2

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2022

As the financial year came to a close large fundraising events were starting to take place and these should ensure an increase in income for the coming year.

Investment policy and financial position

The charity has the power to make any investment which the Trustees see fit. Our investments are managed by Redmayne Bailey and we receive quarterly reports on the value of the Kidneys for Life portfolio. The spread of investments was agreed and a certain approach to risk continued. The charity believes it can generate income which together with investment income will allow the charity to continue for the foreseeable future with its level of charitable payments.

Reserves policy

The events of recent years have had an effect upon the reserves of the Charity and the trustees are aware that it will be imperative that we maintain income to ensure that we are able to have in reserves funding for one year for our travel bursaries, nurse education grants, small research grants scheme and renal research library, £200k approximately. We endeavour to spend in excess of our income, save for restricted funds as detailed in Note 14, leaving sufficient reserves to fund ongoing research as mentioned.

FUTURE PLANS

We will continue to carry out our main activities and our focus on future research, which by its nature is a slow process. Our focus will be:

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document and legal status

The trust is governed by a trust deed dated 6th May 1976 and supplemental deeds of 15th September 1977 and 1st September 1983 and resolution of 4th August 1997, with the scheme further amended on 10th May 2000, 12 July 2007, 11th December 2015, 19th July 2019 and 22nd November 2019.

Recruitment and appointment of new trustees

A trustee can propose the appointment of a trustee, on a proposal a vote shall be taken and approval shall be obtained through a simple majority.

Organisation

The charity is administered from the Renal Unit at Manchester Royal Infirmary. The charity's objects and principal activity consists of charitable fundraising and the provisions of those funds for the advancement of research and provision of direct patient amenities for those suffering from kidney related diseases.

Our trustees are unpaid and details of trustee expenses and any related party transactions are disclosed in note 5 to the accounts.

Decision making

All decisions are made by a consensus of the trustees who represent the Manchester Royal Infirmary, Salford Royal Infirmary and Royal Manchester Children's Hospital.

Trustee induction, training and development

New trustees are provided with an induction pack and are given initial training by the trustees and further training as and when required.

Page 3

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2022

STRUCTURE, GOVERNANCE AND MANAGEMENT

Risk management

The Trustees review the major risks which the Charity faces at Trustee meetings. Trustee meetings take place on a quarterly basis and will continue to do so going forward. In addition to this the Trustees will convene additional meetings to discuss the financial position of the Charity. It is anticipated that by reviewing on a regular basis the Trustees will be able to appropriately adjust the reserves and charitable payments in line with the performance of the Charity. This will allow for the Trustees to provide sufficient resources in the event of adverse conditions. The Trustees have also examined other operational and business risks faced by the Charity and confirm that they have established systems to mitigate the immediate significant risks.

REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number

505256

Principal address

Renal Unit Manchester Royal Infirmary Oxford Road Manchester M13 9WL

Trustees

Trustees
Professor Titus Augustine Consultant Surgeon
Professor Rachel Lennon Consultant Paediatric Physician
Professor Sandip Mitra Consultant Physician
Mr Afshin Tavakoli Consultant Surgeon
Professor Phil Kalra Consultant Physician
Dr Durga Kanigicherla Consultant Nephrologist
Dr Amrit Kaur Consultant in Paediatric Nephrology
Dr Smeeta Sinha Consultant Nephrologist
Dr Michael Picton Consultant Renal Physician

Independent Examiner

Paul Scriven FCCA the Association of Chartered Certified Accountants Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB

Approved by order of the board of trustees on 6 January 2023 and signed on its behalf by:

Mr Afshin Tavakoli - Trustee

Page 4

Ind endeni Examiner'5 Re ori to the Trusttts of KidTre s For Independent eAAminte5 re￿rt to tht trnsttts of KidDryS For tife I rewrt to the Charity tNstees on my examinatK)n of the &counts of Kith￿$ For Life lthe T￿￿) for the ye8r end¢d 30 April ?0?2. Rupon$ibilities And basis of report A5 the charity trnsiees of the Tnjst you are resp)nsible for th¢ preparion of the in XLxTrrknce with the requirements of the Charitie5 Ad 2011 Ilhe Adl. I rep)rt in resrct of my examination of the Twsfs ¥counts canied out under section 145 of the Act and in canying out my examinion I havc folk)wed all applicable Direa1(￿S 8iven by tht Charity C￿MiSsion under stttion 14515Kbl of the Affl. IDdeptndeni euminer's stsiement I ha%'e complded m) examination. I confirni no meriai m•ws have come ￿ my attention in connttthon with the examinatiort giving mc cause w believe in any matrrial res accountin8 records were ￿ k¢w in Yespea of the Tnw as wuirtd b). seaion 130 of the A¢L or the arrounts do not accord with tlK)se records: or Ihe accounts do rK)t comply with the applicable reqUi￿￿￿ts concerning the fonn and content of accounts set out in the Charities (Accounts and Rew)rtsl Regul￿10Th5 ?IK18 Imher than any requirement that the accounts give a tnJ¢ ond fa¢r view which is not a matter considcred as part of an inderndeTrt exatnination. I have concerns and have come auoss Th) oth¢r m•rs irt ¢onne¢tion with the ¢wnin￿lOn w whi¢h 8lleniion should drdwn in this rep)rt in orderto eTthle a prDper under5tsnding of the xcounts ￿ be ￿aChed. Paul ScriNen FCCA lh¢ Associaiion of Chartertd Certified Accountants Pat¢TSOn Brcrtlie Limi*d Chartered Certified Aecoyntants Cliveden Chamber5 Cliveden Place Longton Stoke-on-Trrnt Ststrordshire ST3 4JB 6 January 2023 Page 5

Kidneys For Life

Statement of Financial Activities for the Year Ended 30 April 2022

Unrestricted
funds
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
79,536
Other trading activities
3
67,155
Investment income
4
2,453
Total
149,144
EXPENDITURE ON
Raising funds
62,590
Charitable activities
Expenditure on Charitable Activities
68,292
Total
130,882
Net gains/(losses) on investments
(9,431)
NET INCOME
8,831
Transfers between funds
14
(55,929)
Net movement in funds
(47,098)
RECONCILIATION OF FUNDS
Total funds brought forward
139,638
TOTAL FUNDS CARRIED FORWARD
92,540		 Restricted
funds
£
22,238
32,609
-
54,847
21
37,633
37,654
-
17,193
55,929
73,122
174,339
247,461		 30.4.22
Total
funds
£
101,774
99,764
2,453
203,991
62,611
105,925
168,536
(9,431)
26,024
-
26,024
313,977
340,001		 30.4.21
Total
funds
£
80,669
30,567
1,720
112,956
66,350
68,234
134,584
55,783
34,155
-
34,155
279,822
313,977

CONTINUING OPERATIONS

All income and expenditure has arisen from continuing activities.

The notes form part of these financial statements

Page 6

Kidneys For Life

Balance Sheet
30 April 2022
Unrestricted
funds
Notes
£
FIXED ASSETS
Investments
10
114,537
CURRENT ASSETS
Stocks
11
1,496
Debtors
12
2,977
Cash at bank and in hand
71,802
76,275
CREDITORS
Amounts falling due within one year
13
(98,272)
NET CURRENT ASSETS
(21,997)
TOTAL ASSETS LESS CURRENT
LIABILITIES
92,540
NET ASSETS
92,540		 Restricted
funds
£
176,064
-
1,089
70,598
71,687
(290)
71,397
247,461
247,461		 30.4.22
Total
funds
£
290,601
1,496
4,066
142,400
147,962
(98,562)
49,400
340,001
340,001		 30.4.21
Total
funds
£
299,338
1,533
6,607
35,329
43,469
(28,830)
14,639
313,977
313,977

The notes form part of these financial statements

continued...

Page 7

Kidneys For Life

Balance Sheet - continued 30 April 2022

FUNDS
14
Unrestricted funds:
General fund
Revaluation Fund
Restricted funds:
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney Information
network Recipe
TOTAL FUNDS		 53,260
39,280
92,540
69,071
20,452
149,416
285
3,792
1,102
1,000
1,998
345
247,461
340,001		 90,620
49,018
139,638
36,443
3,427
126,292
285
3,792
1,102
1,000
1,998
-
174,339
313,977

The financial statements were approved by the Board of Trustees and authorised for issue on 6 January 2023 and were signed on its behalf by:

Mr Afshin Tavakoli - Trustee

Professor Rachel Lennon - Trustee

The notes form part of these financial statements

Page 8

Kidneys For Life

Notes to the Financial Statements for the Year Ended 30 April 2022

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets.

Financial reporting standard 102 - reduced disclosure exemptions

The charity has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.The following specific policies are applied to particular categories of income:

Voluntary income is received by way of grants, donations and gifts and is included in full in the statement of financial activities when receivable. Grants, where entitlement is not conditional on the delivery of a specific performance by the charity are recognised when the charity becomes unconditionally entitled to the grant.

Investment income is included when receivable.

Fundraising events income includes all income from both Kidneys for Life led events and those undertaken by supporters.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Expenditure includes any irrecoverable VAT which cannot be fully recovered and is charged against the expenditure to which it relates. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Cost of raising funds comprise of the costs associated with attracting voluntary income and the costs of trading for fundraising purposes.

Charitable expenditure comprise of those costs incurred by the charity in the delivering of its activities and providing grants.

Governance costs include those costs associated with the constitutional and statutory requirements of the Charity and include the accountancy fee and other overhead and support costs.

Tangible fixed assets

Fixed assets (excluding investments) are stated at cost less accumulated depreciation. The costs of minor additions or those costing below £1,000 are not capitalised. Depreciation is provided at rates calculated to write off the cost of each asset over its expected useful life, which in all cases is estimated at 5 years.

continued...

Page 9

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

1. ACCOUNTING POLICIES - continued

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Unrestricted funds include a revaluation reserve representing the restatement of investment assets at current value.

Designated funds are unrestricted funds earmarked by the management committee for particular purposes.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or through the terms of an appeal.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Pension costs and other post-retirement benefits

The Charity operates a defined contribution pension scheme. Contributions payable to the pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

2. DONATIONS AND LEGACIES

DONATIONS AND LEGACIES
30.4.22 30.4.21
£ £
Donations 101,774 80,669

Donations includes £22,238 (2021 - £16,839) relating to the restricted funds for Bladder Exstrophy, Children's Renal Fund (formerly Child Transplant Games), Urology Sports Day, Tameside Dialysis, Adult Games, Polycystic Kidney Disease Research and CAMKIN recipe.

3. OTHER TRADING ACTIVITIES

OTHER TRADING ACTIVITIES
30.4.22 30.4.21
£ £
Fundraising events 99,764 30,567

Fundraising includes £32,609 (2021 - £55) relating to the restricted funds for Children's Renal Fund (formerly Child Transplant Games).

continued...

Page 10

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

4. INVESTMENT INCOME

INVESTMENT INCOME
30.4.22 30.4.21
£ £
Dividend and stock income 2,437 1,706
Deposit account interest 16 14
2,453 1,720

5. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 30 April 2022 nor for the year ended 30 April 2021.

Trustees' expenses

There were no trustees' expenses paid or travel bursaries awarded during the year ended 30 April 2022 nor for the year ended 30 April 2021.

6. STAFF COSTS

The average monthly number of employees during the year was as follows:

30.4.22 30.4.21
Staff 1 1

No employees received emoluments in excess of £60,000.

7. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
63,830
Other trading activities
30,512
Investment income
1,720
Total
96,062
EXPENDITURE ON
Raising funds
66,184
Charitable activities
Expenditure on Charitable Activities
44,115
Total
110,299
Net gains on investments
55,783
NET INCOME/(EXPENDITURE)
41,546
Transfers between funds
20,578		 Restricted
funds
£
16,839
55
-
16,894
166
24,119
24,285
-
(7,391)
(20,578)		 Total
funds
£
80,669
30,567
1,720
112,956
66,350
68,234
134,584
55,783
34,155
-

continued...

Page 11

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Net movement in funds
62,124
(27,969)
RECONCILIATION OF FUNDS
Total funds brought forward
77,514
202,308
TOTAL FUNDS CARRIED FORWARD
139,638
174,339
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.22
£
Share dealing - gains
307
Share dealing - losses
-
307
Unrealised (loss)/gain on revaluation
(9,738)
(9,431)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
120
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2021 and 30 April 2022
1,518
13,535
DEPRECIATION
At 1 May 2021 and 30 April 2022
1,518
13,535
NET BOOK VALUE
At 30 April 2022
-
-
At 30 April 2021
-
-		 7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Net movement in funds
62,124
(27,969)
RECONCILIATION OF FUNDS
Total funds brought forward
77,514
202,308
TOTAL FUNDS CARRIED FORWARD
139,638
174,339
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.22
£
Share dealing - gains
307
Share dealing - losses
-
307
Unrealised (loss)/gain on revaluation
(9,738)
(9,431)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
120
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2021 and 30 April 2022
1,518
13,535
DEPRECIATION
At 1 May 2021 and 30 April 2022
1,518
13,535
NET BOOK VALUE
At 30 April 2022
-
-
At 30 April 2021
-
-		 7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Net movement in funds
62,124
(27,969)
RECONCILIATION OF FUNDS
Total funds brought forward
77,514
202,308
TOTAL FUNDS CARRIED FORWARD
139,638
174,339
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.22
£
Share dealing - gains
307
Share dealing - losses
-
307
Unrealised (loss)/gain on revaluation
(9,738)
(9,431)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
120
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2021 and 30 April 2022
1,518
13,535
DEPRECIATION
At 1 May 2021 and 30 April 2022
1,518
13,535
NET BOOK VALUE
At 30 April 2022
-
-
At 30 April 2021
-
-		 7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Net movement in funds
62,124
(27,969)
RECONCILIATION OF FUNDS
Total funds brought forward
77,514
202,308
TOTAL FUNDS CARRIED FORWARD
139,638
174,339
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.22
£
Share dealing - gains
307
Share dealing - losses
-
307
Unrealised (loss)/gain on revaluation
(9,738)
(9,431)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
120
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2021 and 30 April 2022
1,518
13,535
DEPRECIATION
At 1 May 2021 and 30 April 2022
1,518
13,535
NET BOOK VALUE
At 30 April 2022
-
-
At 30 April 2021
-
-		 Total
funds
£
34,155
279,822
313,977
30.4.22 30.4.21
£ £
307 14,428
- (4,581)
307 9,847
(9,738) 45,936
(9,431) 55,783
£ £
120 480
Computer
equipment
£
13,535
13,535
-
-		 Totals
£
15,053
15,053
-
-

continued...

Page 12

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

10. FIXED ASSET INVESTMENTS

Fixed asset investments consist of the Kidneys for Life Portfolio. The Portfolio is valued at current market value at the year end date

11. STOCKS
30.4.22 30.4.21
£ £
Finished goods 1,496 1,533
12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.22 30.4.21
£ £
Other debtors 2,543 2,017
Provision for tax rebate 470 2,446
Prepayments 1,053 2,144
4,066 6,607
13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.22 30.4.21
£ £
Trade creditors 56,973 20,229
Taxation and social security (28) 171
Other creditors 41,617 8,430
98,562 28,830

continued...

Page 13

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

14. MOVEMENT IN FUNDS

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
TOTAL FUNDS
Net movement in funds, included in the above are as
Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Cheshire and Merseyside Kidney
Information network Recipe
TOTAL FUNDS		 At 1.5.21
£
90,620
49,018
-
139,638
36,443
3,427
126,292
285
3,792
1,102
1,000
1,998
-
174,339
313,977
follows:
Incoming
resources
£
149,144
-
-
149,144
34,908
19,594
-
345
54,847
203,991		 Net
movement
in funds
£
34,183
(9,738)
(15,614)
8,831
32,628
17,025
(32,805)
-
-
-
-
-
345
17,193
26,024
Resources
expended
£
(115,268)
-
(15,614)
(130,882)
(2,280)
(2,569)
(32,805)
-
(37,654)
(168,536)		 Transfers
between
At
funds
30.4.22
£
£
(71,543)
53,260
-
39,280
15,614
-
(55,929)
92,540
-
69,071
-
20,452
55,929
149,416
-
285
-
3,792
-
1,102
-
1,000
-
1,998
-
345
55,929
247,461
-
340,001
Gains and
Movement
losses
in funds
£
£
307
34,183
(9,738)
(9,738)
-
(15,614)
(9,431)
8,831
-
32,628
-
17,025
-
(32,805)
-
345
-
17,193
(9,431)
26,024

continued...

Page 14

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

14. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
TOTAL FUNDS		 At 1.5.20
£
74,438
3,076
-
77,514
23,320
-
173,698
401
3,912
977
-
-
202,308
279,822		 Net
movement
in funds
£
(326)
45,936
(4,064)
41,546
13,123
421
(23,822)
(116)
(120)
125
1,000
1,998
(7,391)
34,155		 Transfers
between
funds
£
16,508
6
4,064
20,578
-
3,006
(23,584)
-
-
-
-
-
(20,578)
-		 At
30.4.21
£
90,620
49,018
-
139,638
36,443
3,427
126,292
285
3,792
1,102
1,000
1,998
174,339
313,977

Comparative net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
TOTAL FUNDS		 Incoming
resources
£
96,062
-
-
96,062
13,348
421
-
-
-
125
1,000
2,000
16,894
112,956		 Resources
expended
£
(106,235)
-
(4,064)
(110,299)
(225)
-
(23,822)
(116)
(120)
-
-
(2)
(24,285)
(134,584)		 Gains and
Movement
losses
in funds
£
£
9,847
(326)
45,936
45,936
-
(4,064)
55,783
41,546
-
13,123
-
421
-
(23,822)
-
(116)
-
(120)
-
125
-
1,000
-
1,998
-
(7,391)
55,783
34,155		 Gains and
Movement
losses
in funds
£
£
9,847
(326)
45,936
45,936
-
(4,064)
55,783
41,546
-
13,123
-
421
-
(23,822)
-
(116)
-
(120)
-
125
-
1,000
-
1,998
-
(7,391)
55,783
34,155
41,546
13,123
421
(23,822)
(116)
(120)
125
1,000
1,998
(7,391)
34,155

Page 15

continued...

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

14. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
TOTAL FUNDS		 At 1.5.20
£
74,438
3,076
-
77,514
23,320
-
173,698
401
3,912
977
-
-
-
202,308
279,822		 Net
movement
in funds
£
33,857
36,198
(19,678)
50,377
45,751
17,446
(56,627)
(116)
(120)
125
1,000
1,998
345
9,802
60,179		 Transfers
between
funds
£
(55,035)
6
19,678
(35,351)
-
3,006
32,345
-
-
-
-
-
-
35,351
-		 At
30.4.22
£
53,260
39,280
-
92,540
69,071
20,452
149,416
285
3,792
1,102
1,000
1,998
345
247,461
340,001

Page 16

continued...

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

14. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
TOTAL FUNDS		 Incoming
resources
£
245,206
-
-
245,206
48,256
20,015
-
-
-
125
1,000
2,000
345
71,741
316,947		 Resources
expended
£
(221,503)
-
(19,678)
(241,181)
(2,505)
(2,569)
(56,627)
(116)
(120)
-
-
(2)
-
(61,939)
(303,120)		 Gains and
Movement
losses
in funds
£
£
10,154
33,857
36,198
36,198
-
(19,678)
46,352
50,377
-
45,751
-
17,446
-
(56,627)
-
(116)
-
(120)
-
125
-
1,000
-
1,998
-
345
-
9,802
46,352
60,179

Purpose of funds

Designated Fund

The purpose of the designated funds is to provide for travel bursaries, upkeep of the renal library, small grants scheme and educational grants for renal staff and direct patient amenities.

Revaluation Fund

The revaluation fund recognises the amount by which the investments exceed their historical cost.

Bladder Exstrophy Fund

This fund is for use by the Bladder Exstrophy Team at Royal Manchester Children's Hospital to facilitate their annual Christmas Party, medical equipment and research funding.

Children's Renal Fund (formerly Child Transplant Games)

This fund is for use by the Children's Renal Team at Royal Manchester Children's Hospital to facilitate the attendance of the Manchester Children's Transplant Games Team at the British Transplant Games each year, purchase of medical equipment, patient amenities for the wards and staff education.

Kidney Info Network

We work with GMKIN (Greater Manchester Kidney Information Network) to provide a social media presence for kidney patients in the North West. The fund is for use in maintaining this presence.

continued...

Page 17

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2022

14. MOVEMENT IN FUNDS - continued

Purpose of funds - continued

Tameside Dialysis Fund

Kidneys for Life received a donation in memory of a Tameside Dialysis patient and with the request that these funds be spent at Tameside Dialysis Unit. The staff at the Unit are aware of this donation and will communicate with Kidneys for Life when they decide how they would like this money to be spent.

Urology Sports Day Fund

The Urology Sports Day was set up by Dr Anju Goyal and was paid for using funds from the Urology Fund which Kidneys for Life administers as per the MOU on their behalf. It is to be used to facilitate an annual event.

Adult Games Fund

Kidneys for Life received a donation with the request that these funds be spent on adult games.

Polycystic Kidney Disease Research Fund

Kidneys for Life received a donation with the request that these funds be spent on polycystic kidney disease research.

Cheshire and Merseyside Kidney Information Network Recipe Fund

Received donations to fund a special renal recipe book.

15. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 30 April 2022, except for a transaction of £350 with a company Professor Phil Kalra is a member of and has a position of control/management.

All trustees remove themselves from any decision if they have a related party connection with the company being discussed.

16. FABRY NEPHROPATHY CONFERENCE FUND

A separate bank account was opened to facilitate the income and expenditure for the bi-annual conference. The next conference is scheduled to take place in Germany in May 2022. The movement on the account is shown below. The end balance equating to the balance on the bank account at the 30th April 2022.

Balance at Balance at
1.5.21 Incoming Outgoing 30.4.22
£ £ £ £
Movement to date 61,784 219,827 43,529 238,082

The Fabry bank account was owed £32,740 by Kidneys for life at the 30th April 2022.

Page 18

Kidneys For Life

INCOME AND ENDOWMENTS
Donations and legacies
Donations
Other trading activities
Fundraising events
Investment income
Dividend and stock income
Deposit account interest
Total incoming resources
EXPENDITURE
Raising donations and legacies
Wages
Postage and miscellaneous
Promotional costs
Event costs
Travel costs
Card fees
Christmas cards
Charitable activities
Grant management
Bladder Exstrophy Fund
Miscellaneous grants
Ward and medical equipment
Travel & conference bursaries
Small research grants
Nurse education
Patient support
Publication grants
Support costs
Governance costs
Governance management
Insurance
Carried forward		 Detailed Statement of Financial Activities
for the Year Ended 30 April 2022
30.4.22
30.4.21
£
£
101,774
80,669
99,764
30,567
2,437
1,706
16
14
2,453
1,720
203,991
112,956
34,190
48,169
2,069
4,111
10,600
5,877
12,478
4,198
74
270
1,062
961
2,138
2,764
62,611
66,350
17,304
16,502
2,345
-
13,340
3,535
118
100
1,213
-
32,805
23,822
300
300
2,426
310
700
-
70,551
44,569
12,360
11,787
607
677
12,967
12,464		 Detailed Statement of Financial Activities
for the Year Ended 30 April 2022
30.4.22
30.4.21
£
£
101,774
80,669
99,764
30,567
2,437
1,706
16
14
2,453
1,720
203,991
112,956
34,190
48,169
2,069
4,111
10,600
5,877
12,478
4,198
74
270
1,062
961
2,138
2,764
62,611
66,350
17,304
16,502
2,345
-
13,340
3,535
118
100
1,213
-
32,805
23,822
300
300
2,426
310
700
-
70,551
44,569
12,360
11,787
607
677
12,967
12,464
1,720
112,956
48,169
4,111
5,877
4,198
270
961
2,764
66,350
16,502
-
3,535
100
-
23,822
300
310
-
44,569
11,787
677
12,464

This page does not form part of the statutory financial statements

Page 19

Kidneys For Life

Detailed Statement of Financial Activities

Detailed Statement of Financial Activities
for the Year Ended 30 April 2022
30.4.22 30.4.21
£ £
Governance costs
Brought forward 12,967 12,464
Telephone 848 1,168
Accountancy 3,122 2,870
Investment management 2,795 2,789
Office Equipment & Computer Maintenance
and Updates 15,642 4,374
35,374 23,665
Total resources expended 168,536 134,584
Net income/(expenditure) before gains and
losses 35,455 (21,628)
Realised recognised gains and losses
Realised gains/(losses) on fixed asset investments 307 9,847
Profit/(loss) on revaluation of investments (9,738) 45,936
Net income 26,024 34,155

This page does not form part of the statutory financial statements

Page 20